Should you buy Metcash Limited in 2014?

Rivals upping pressure on independent stores.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Metcash Limited (ASX: MTS) shares have rebounded mildly from their April 2014 low of $2.54 to trade today at around $2.92. The 15% jump has been great for investors that got in at the right time, but should investors be confident that the share price will continue rising?

Background

Metcash is a wholesaler of groceries to around 2,500 independent grocery stores around Australia. The share price plunged to a near 10-year low in April when the company announced that profit would fall by up to 15% this year, while the dividend payout will fall by over 25% as the payout ratio would be cut from 80% to 60% on lower profits.

Major Rivals

The root of Metcash's problems is that it cannot sell goods to its network of supermarkets at a price that will allow them to compete with major rivals Woolworths Limited (ASX: WOW) and Coles, owned by Wesfarmers Ltd (ASX: WES).

Metcash plans on spending $625 million over five years on creating a world-class supply chain, refurbishing and consolidating existing supermarkets,  and improving its fresh food offering in order to arrest the trend of falling sales and margins.

Will It Be Enough?

I don't think so. Metcash is spending a lot of cash on its attempt to improve its offering over that of its rivals, but as evidenced by the Wesfarmers strategy day last week, rivals are not standing still. Coles' management believe they have a long way to go yet in supply chain efficiency and fresh food sales. The company believes prices will continue to be driven lower by competition from Woolworths, but also from international chains such as Aldi and Costco.

Metcash also have to contend with the increased presence and saturation of rival stores. With $2 billion being spent on 180 new Coles and Woolworths stores nationwide, the 'convenience' offered by independent grocers will be eroded further.

Forecasts

Analyst forecasts for the company are fairly unanimous in expecting a fall in profits both in FY14 and FY15. A reduction in payout ratio from 80% to 60% could see the dividend fall to 17 cents per share in FY14 and around 15 cents in FY15. This would represent nearly a 50% fall in dividend over two years.

Motley Fool contributor Andrew Mudie does not own shares in any companies mentioned. You can find Andrew on Twitter @andrewmudie

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »